 | Up a level |
Hoffmann, Michèle; Schardt, Julian; Ionescu, Codruta; Wolf-Schnurrbusch, Ute E.; Wagner, Franca; Dettmer, Matthias S.; Olariu, Radu; Özdemir, Berna C. (2021). Long lasting response to anti-PD-1 therapy of recurrent conjunctival squamous cell carcinoma - A case report and systematic review of the literature. Current problems in cancer: case reports, 4, p. 100088. Elsevier 10.1016/j.cpccr.2021.100088
Schardt, Julian (2020). [The use of immune checkpoint inhibitors in routine oncology]. Zeitschrift für Rheumatologie, 79(8), pp. 809-817. Springer-Medizin-Verlag 10.1007/s00393-020-00876-2
Cathomas, Richard; Schardt, Julian; Pless, Miklos; Llado, Anna; Mach, Nicolas; Riklin, Christian; Haefeli, Jenny; Fear, Simon; Stenner, Frank (2020). Swiss experience of atezolizumab for platinum-pretreated urinary tract carcinoma: the SAUL study in real-world practice. Swiss medical weekly, 150(w20223), pp. 1-7. EMH Media 10.4414/smw.2020.20223
Schardt, Julian; Roth, Beat; Seiler, Roland (2019). Forty years of cisplatin-based chemotherapy in muscle-invasive bladder cancer: are we understanding how, who and when? World journal of urology, 37(9), pp. 1759-1765. Springer-Verlag 10.1007/s00345-018-2544-8
Bill, Ruben; Schardt, Julian (2019). [Immunotherapies - Overview, mode of action and clinical implications]. Therapeutische Umschau, 76(4), pp. 187-194. Hogrefe 10.1024/0040-5930/a001083
Lengwiler, Emanuel; Stampf, Susanne; Zippelius, Alfred; Salati, Emanuela; Zaman, Khalil; Schäfer, Niklaus; Schardt, Julian; Siano, Marco; Hofbauer, Günther (2019). Solid cancer development in solid organ transplant recipients within the Swiss Transplant Cohort Study. Swiss medical weekly, 149, w20078. EMH Media 10.4414/smw.2019.20078
Sandmeier, Nadja; Rothschild, Sacha I; Rothermundt, Christian; Cathomas, Richard; Schardt, Julian; Berthold, Dominik; von Burg, Philippe; Müller, Beat; Beyer, Jörg; Vogt, Deborah R; Stenner, Frank (2018). Pattern of Care Study in Metastatic Renal-Cell Carcinoma in the Preimmunotherapy Era in Switzerland. Clinical genitourinary cancer, 16(4), e711-e718. Elsevier 10.1016/j.clgc.2018.01.002
Gössi, Flavio; Spahn, Martin; Samaras, Panagiotis; Beyer, Jörg; Schardt, Julian; Pabst Müller, Thomas Niklaus (2018). Response to first-line treatment and histology are associated with achieving complete remission after the first salvage high-dose chemotherapy in relapsing germ cell tumor patients. Bone marrow transplantation, 53(7), pp. 820-825. Nature Publishing Group 10.1038/s41409-018-0089-5
Gössi, F; Spahn, Martin; Zweifel, Martin; Panagiotis, S; Mischo, A; Stenner, F; Hess, U; Berthold, D; Bargetzi, M; Schardt, Julian; Pabst, Thomas (2017). Comparison of three or fewer high-dose chemotherapy cycles as salvage treatment in germ cell tumors in first relapse. Bone marrow transplantation, 52(2), pp. 334-336. Nature Publishing Group 10.1038/bmt.2016.285
Schardt, Julian; Keller, Manuela; Seipel, Katja; Pabst, Thomas (2015). Functional interplay of SP family members and nuclear factor Y is essential for transcriptional activation of the human Calreticulin gene. Biochimica et biophysica acta - gene regulatory mechanisms, 1849(9), pp. 1188-1197. Elsevier 10.1016/j.bbagrm.2015.07.003
